❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Annual reports ❭

Annual reports

Download reports in PDF format:

2025 Single page format Double page format  
2024 Single page format Double page format  
2023 Single page format Double page format  
2022 Single page format Double page format  
2021 Single page format Double page format  
2020 Single page format Double page format Abstract (in Norwegian)
2019 Single page format Double page format Abstract (in Norwegian)
2018 Single page format Double page format Abstract (in Norwegian)
2017 Single page format Double page format  
2016 Single page format Double page format  
2015 Single page format    
2014 Single page format    

 

 
Scroll to top

Home Cancer Medicine Institute for Cancer Research

  • Dept. of Cancer Genetics
  • Dept. of Cancer Immunology
  • Dept. of Molecular Cell Biology
  • Dept. of Molecular Oncology
  • Dept. of Radiation Biology
  • Dept. of Tumor Biology
  • Dept. of Core Facilities
  • Institute employees
  • Dept./group overview
  • Publications
  • Institute administration
  • Annual reports
  • Institute seminars
  • Vacant positions
  • News archive
  • Scientific Advisory Board
  • ehåndbok/HES procedures

Recent publications

From major journals, first or last author from the Institute for Cancer Research

Vedeld HM, Breder S, Pharo H, Brodal HP, Adolfsen EM, Brandt-Winge S, von Seth E, Grimsrud MM, Yaqub S, Karlsen TH, Grzyb K, Paulsen V, Färkkilä MA, Bergquist A, Aabakken L, Boberg KM, Folseraas T, Lind GE (2026)
Accurate detection of cholangiocarcinoma in primary sclerosing cholangitis by DNA methylation biomarkers in bile and plasma
JHEP Rep, 101876 (in press)
DOI 10.1016/j.jhepr.2026.101876, PubMed 42067191

Ayuda-Durán P, Hanes R, Rønneberg L, Alver TN, Øy GF, Hauge S, Andersen AN, Egeland EV, Juell S, Nakken S, Asenso TQ, Zucknick M, Syljuåsen RG, Mælandsmo GM, Hovig E, Enserink JM (2026)
Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential
Commun Med (Lond) (in press)
DOI 10.1038/s43856-026-01583-w, PubMed 42062484

Casas-Arozamena C, Lande KT, Diaz E, Vilar A, Cueva J, Arias E, Sampayo V, Abalo A, González N, Colás E, Gil-Moreno A, Abal M, Moreno-Bueno G, Sørlie T, Lindemann K, Muinelo-Romay L (2026)
Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off-the-shelf targeted NGS panel
Mol Oncol (in press)
DOI 10.1002/1878-0261.70246, PubMed 42047179

More selected publications

Most recent publications

Nagel R, Kochavi A, Flem-Karlsen K, Adhikary M, Gal-On Y, Klaoudatou MG, Champagne J, Valcanover L, Palashati H, Nielsen MM, Feng X, Körner PR, Giebel L, Yang W, Velds A, Hoekman L, Bleijerveld OB, van Tellingen O, Olweus J, Agami R (2026)
Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production
Cancer Res (in press)
DOI 10.1158/0008-5472.CAN-25-4773, PubMed 42095547

Zhang W, Brown EL, Usmani A, Earland N, Kang M, Olelewe C, Viswanathan A, Chauhan PS, Steen CB, Jeon HS, Avagyan S, Alahi I, Semenkovich NP, Schwab JC, Sachs CM, Qaium F, Harris PK, Cai Q, Gentles AJ, Knight J, Graham RP, Bacchiocchi A, Lucas PC, Fields RC, Sznol M et al. (2026)
Non-invasive profiling of the tumour microenvironment with spatial ecotypes
Nature (in press)
DOI 10.1038/s41586-026-10452-4, PubMed 42092150

Burk L, Zobolas J, Bischl B, Bender A, Wright MN, Sonabend R (2026)
A large-scale neutral comparison study of survival models on low-dimensional data
Bioinformatics, 42 (5)
DOI 10.1093/bioinformatics/btag186, PubMed 41992491

More publications

Annual summary of publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)